Register Now: IKRIS Breast Cancer Awareness Run 2022

Search results for:assisted more

The US FDA approves Sarclisa together with Carfilzomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma

The FDA has approved Sarclisa, together with Kyprolis and dexamethasone (Kd), in order to treat adult patients with the relapsed […]

April 5, 2021

5-Minutes Novel Breast Cancer Treatment Rolled Out in UK by National Health Service

A novel breast cancer jab will lessen the time period patients have to pass in hospital from two-and-a-half hours to […]

April 8, 2021

Teclistamab Shows High Response Rate and Good Tolerability Profile in Patients with Multiple Myeloma

According to outcomes from an ongoing study presented during the II’nd European Myeloma Network Meeting, Teclistamab shows high response rate […]

April 21, 2021


WHAT IS OCTREOTIDE AND WHAT IT IS USED FOR: Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin […]

December 4, 2020

World Health Organization to begin clinical trial on new repurposed drugs for severe cases of COVID-19

‘Solidarity’, an international clinical trial launched by the World Health Organization in order to help investigate an absolutely effective treatment […]

May 17, 2021

How Risky is Black Fungus? What are the Symptoms and Treatment?

COVID-associated black fungus has especially affected individuals in India. The association also appeared in Russia. One elaboration for why the […]

May 24, 2021

COVID-19 Vaccine AstraZeneca is now authorized across the EU

COVID-19 Vaccine AstraZeneca is a vaccine, approved in order to prevent the COVID-19 in people aged 18 years and older. […]

February 1, 2021


We as Ikris Pharma Network supply products to all the people involved in supply chain of Healthcare distribution. This include […]

October 23, 2020

Generic medicine: Impact on lower and middle-income countries

Generic medicines are those medications that are bioequivalent as the innovator drug. Generic medicine contains the same active ingredients, is […]

May 5, 2022

Apretude Injection: Beacon of hope in the prevention of HIV infection

The U.S FDA (Food and Drugs Administration) approved the first injectable medication for HIV pre-exposure prevention on December 20, 2021, […]

January 11, 2022